Efficacy and safety findings from DREAM: a phase III study of DHP107 (oral paclitaxel) versus i.v. paclitaxel in patients with advanced gastric cancer after failure of first-line chemotherapy.
Kang YK, Ryu MH, Park SH, Kim JG, Kim JW, Cho SH, Park YI, Park SR, Rha SY, Kang MJ, Cho JY, Kang SY, Roh SY, Ryoo BY, Nam BH, Jo YW, Yoon KE, Oh SC.
Kang YK, et al. Among authors: park yi, park sr, park sh.
Ann Oncol. 2018 May 1;29(5):1220-1226. doi: 10.1093/annonc/mdy055.
Ann Oncol. 2018.
PMID: 29438463
Free article.
Clinical Trial.